
Single Cell Technology
Oct 25, 2023 · Single Cell Technology is a group of dedicated scientists and engineers who’ve spent the last decade figuring out how to eliminate the obstacles that have limited antibody …
About Us - Single Cell Technology
Learn about Single Cell Technology, and how we went from a barcode scanner to our groundbreaking Abtheneum antibody discovery platform.
AbTherx Partners with Single Cell Technology for First Antibody ...
Mar 13, 2024 · Single Cell is a leading antibody discovery R&D provider. Its pioneering AbTheneum™ platform compresses campaign timelines and captures all binder and non …
SurfScreen Pilot for TIGIT - Single Cell Technology
Oct 25, 2023 · This project used a recombinant extracellular domain (ECD) of TIGIT to immunize the mice, and it is common that antibodies derived from that type of immunogen do not always …
AbTherx, SCT and Vaccinex Announce Collaboration
May 13, 2025 · We are excited to announce a collaboration between AbTherx, Single Cell Technology, and Vaccinex to tackle challenging antibody drug targets.
Sorted cell populations from HSA-immunized mice lymphocytes were deposited onto several picowell devices. All secreted IgGs are captured on an antibody capture slide and assessed …
Using Human Cells for Broadly Reactive Influenza Antibody …
Oct 25, 2023 · Single Cell used an in-house cytokine cocktail to activate cells over 5 days. On Day 3, cells were enriched for target-specific cells using the MACSQuant Tyto cell sorter.
Our Science - Single Cell Technology
Instead of having to literally pick just a handful of cells to work with early in the process – and leave huge amounts of data and possible pathways unexplored – it’s now possible to collect …
AET US 2025 - singlecelltechnology.com
Oct 21, 2025 · At Antibody Engineering & Therapeutics, Single Cell will be celebrating 10 years of AbTheneum antibody discovery services at Booth 310.
News - Single Cell Technology
Mar 13, 2024 · AbTherx, Single Cell Technology, and Vaccinex Announce Collaboration to Tackle Challenging Antibody Drug Targets 22 April 2025